Related Experiment Videos
Management of endobronchial tumors: a comparative study
J S McCaughan1, P C Hawley, J Walker
1Laser Medical Research Foundation, Columbus, Ohio.
Seminars in Surgical Oncology
|January 1, 1989
Summary
Photodynamic therapy (PDT) and laser treatments show promise for endobronchial and endotracheal diseases. Some patients achieved long-term survival and no evidence of disease, particularly with PDT.
Area of Science:
- Pulmonology
- Oncology
- Laser Medicine
Background:
- Endobronchial and endotracheal diseases pose significant treatment challenges.
- Previous treatment modalities had limitations in efficacy and safety.
Purpose of the Study:
- To evaluate the efficacy and survival outcomes of CO2 laser, Nd:YAG laser, and photodynamic therapy (PDT) for endobronchial/endotracheal diseases.
- To assess the safety profile of these treatment modalities.
Main Methods:
- A retrospective analysis of 102 patients treated between September 1982 and July 1987.
- Treatments included CO2 laser, Nd:YAG laser, and photodynamic therapy (PDT), often in combination.
- Detailed records of treatments, survival, and disease status were maintained.
Main Results:
- 11 patients survived over 1 year, with 4 surviving >18 months; 7 achieved no evidence of disease (all PDT treated).
- PDT demonstrated no intraoperative complications (deaths, bleeding, smoke).
- Pulmonary hemorrhage occurred in 8 patients (4 Nd:YAG alone, 4 PDT alone) 2-9 weeks post-treatment.
Conclusions:
- Photodynamic therapy (PDT) shows potential for durable, complication-free treatment of endobronchial/endotracheal diseases.
- Laser therapies (Nd:YAG, CO2) and PDT can offer survival benefits in severely ill patients.
- Careful patient selection and consideration of treatment-related risks are crucial for optimizing outcomes.